Oxidative Stress in Motor Neuron Disease: COSMOS Add-On Study
Oxidative Stress in Motor Neuron Disease: COSMOS-PLS Add-On Study
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
Listed as NCT01143428, this observational or N/A phase trial focuses on Motor Neuron Disease and Primary Lateral Sclerosis and remains completed. Sponsored by National Institute of Neurological Disorders and Stroke (NINDS), it has been updated 15 times since 2010, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
15 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Dec 2019 — Jan 2021 [monthly]
Completed
-
Sep 2019 — Dec 2019 [monthly]
Completed
▶ Show 10 earlier versions
-
Jul 2019 — Sep 2019 [monthly]
Completed
-
Jun 2019 — Jul 2019 [monthly]
Completed
-
May 2019 — Jun 2019 [monthly]
Completed
-
Mar 2019 — May 2019 [monthly]
Completed
-
Feb 2019 — Mar 2019 [monthly]
Completed
-
Aug 2018 — Feb 2019 [monthly]
Completed
-
Jul 2018 — Aug 2018 [monthly]
Completed
-
Jun 2018 — Jul 2018 [monthly]
Completed
-
Apr 2018 — Jun 2018 [monthly]
Completed
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Completed NA
First recorded
May 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Institute of Neurological Disorders and Stroke (NINDS)
For direct contact, visit the study record on ClinicalTrials.gov .